Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
06/2010
06/03/2010US20100137271 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100137200 Methods for treatment of growth disorders
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136109 Sustained release
06/03/2010US20100136105 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100135979 Stabilized suspension
06/03/2010US20100135956 Steroid modulators of progesterone receptor and/or glucocorticoid receptor
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2743976A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
06/02/2010EP2191833A1 Transdermally absorbable preparation
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2191829A2 Treatment of endocrine dysfunction using iron chelators
06/02/2010EP1562901B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/02/2010CN101717416A Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof
06/02/2010CN101716135A Soy isoflavone solid dispersion suppository and preparation method thereof
06/02/2010CN101715956A Multifunctional health juice with stable effective ingredients and processing method thereof
06/02/2010CN101219114B Pennogenin compounds solid state molecule dispersion preparation
06/01/2010US7728042 Transdermal pharmaceutical composition
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
06/01/2010US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs
06/01/2010CA2431888C Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
06/01/2010CA2388237C Treatment of osteoporosis
05/2010
05/27/2010WO2010057260A1 Method for treating or preventing a pancreatic dysfunction
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100129458 Compositions and methods for inhibiting reproduction in tadpole shrimp
05/27/2010CA2744228A1 Method for treating or preventing a pancreatic dysfunction
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2188301A2 Novel steroidal esters of 17-oximino-5-androsten-3 beta-ol
05/26/2010EP2188293A1 6-substituted sulfonyl azabicycloý3.2.1¨octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
05/26/2010EP1585727B1 Indoles useful in the treatment of androgen-receptor related diseases
05/26/2010EP1562946B1 Novel xanthine derivatives, the production and the use thereof in the form of drugs
05/26/2010EP1537113B9 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1684709B Medicine carrier for local application
05/26/2010CN101712653A Pyridazine derivatives and their use as therapeutic agents
05/26/2010CN101711756A Application of 3-phenyl-3-(4-nitryl phenylamino)-1-(4-chlorphenyl)-1-acetone as non-steroidal androgen receptor regulating agent
05/25/2010US7723489 blocking the binding of thyrotropin with a receptor; treating hyperthyroidism, Graves' disease ophthalmopathy
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
05/25/2010US7723320 Use of estrogen compounds to increase libido in women
05/25/2010CA2402667C 6-oxygenated steroidal estrogens with aromatic a and b rings
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2245890C Use of an extract of cimicifuga racemosa
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010054565A1 The water-soluble prodrug of (r)-(-)-bicalutamide, its preparation method and uses thereof
05/20/2010WO2010054438A1 Aryl di-substituted propenone compounds
05/20/2010US20100124535 Aerosol Dispersions of Particles with Active Pharmaceutical Ingredients
05/20/2010CA2743661A1 Aryl di-substituted propenone compounds
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/19/2010EP2186513A1 Use of specific cyclolignans
05/19/2010EP2185510A2 New salts of bazedoxifene
05/19/2010EP2185157A1 Dhea compositions for treating menopause
05/19/2010CN101711252A heterocyclic spiro-compounds
05/19/2010CN101708317A Chinese medicinal composition for treating thyroid disease
05/18/2010US7718666 Pyrido [2,1-a] isoquinoline derivatives
05/18/2010US7718605 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain
05/18/2010US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases
05/18/2010US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
05/18/2010CA2472475C 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2402193C Novel lhrh-antagonists, production and use thereof as medicament
05/14/2010WO2010054286A2 Substituted hydroxyphenylamine compounds
05/14/2010WO2010052563A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
05/14/2010CA2743026A1 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
05/14/2010CA2727520A1 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
05/13/2010US20100120887 Sustained release formulation of melatonin
05/13/2010US20100120883 Novel compounds
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120751 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/13/2010US20100120733 Steroid modulators of glucocorticoid receptor
05/13/2010US20100120707 Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
05/13/2010US20100120705 Compositions and products containing s-equol, and methods for their making
05/13/2010US20100120686 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
05/13/2010US20100120015 Method of collecting placental stem cells
05/13/2010US20100119609 Methods, compositions, and formulations for the treatment of thyroid eye disease
05/12/2010EP2184277A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof
05/12/2010EP2183267A2 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl) nonyl]estra-1,3,5(10)-triene-3,17-beta-diol
05/12/2010EP2182965A1 Extracts of ligustrum lucidum and uses thereof
05/12/2010EP1644397B1 Specific glucocorticosteroid compound having anti- inflammatory activity
05/12/2010CN1835762B Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1736371B Selective androgen receptor modulators and methods of use thereof
05/12/2010CN1642577B Preparation comprising buprenorphine
05/12/2010CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby
05/12/2010CN1466451B Ion-strength independent sustained release pharmacetuical formulation
05/12/2010CN101703486A Novel flutamide tablets and method for preparing same
05/12/2010CN101120951B Ovarian moisturing soft capsule and preparing process thereof
05/11/2010US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
05/11/2010US7714108 Mammalian tumor susceptibility gene products and their uses
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2355651C Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
05/06/2010WO2010050508A1 Peptide having anti-diabetic activity and use thereof
05/06/2010WO2010049678A2 Treatment of energy utilization diseases
05/06/2010WO2009144278A3 Conglutin-gamma as medicament and diet supplement
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 290